BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9187425)

  • 1. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
    Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging.
    Bergan R; Hakim F; Schwartz GN; Kyle E; Cepada R; Szabo JM; Fowler D; Gress R; Neckers L
    Blood; 1996 Jul; 88(2):731-41. PubMed ID: 8695822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene.
    Heufelder AE; Bahn RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1420-32. PubMed ID: 7775120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of c-myc antisense oligodeoxynucleotide transfected by liposome on HL-60 cells].
    Chen L; Zhuo G; Chen Z
    Zhonghua Nei Ke Za Zhi; 2000 Oct; 39(10):660-3. PubMed ID: 11374170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
    Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
    J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells.
    Kimura S; Maekawa T; Hirakawa K; Murakami A; Abe T
    Cancer Res; 1995 Mar; 55(6):1379-84. PubMed ID: 7882339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
    Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect and mechanism of VEGF antisense phosphorothioate deoxynucleotides on HL-60 leukemic cells].
    Fei J; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):640-3. PubMed ID: 15498126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
    Watson PH; Pon RT; Shiu RP
    Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of apoptosis and inhibition of HL-60 cell proliferation by survivin antisense oligonucleotide].
    Zhu YS; Guo X; Ge J
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):97-100. PubMed ID: 16613698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells.
    Joshi S; Wu A; Verbik D; Algarra S; Bishop M; Pirruccello S; Iversen P; Jackson J; Kessinger M; Sharp J
    Int J Oncol; 1996 Apr; 8(4):815-20. PubMed ID: 21544432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.
    Stewart DA; Thomas SD; Mayfield CA; Miller DM
    Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of SK-MEL-30 human melanoma cells by antisense c-myc oligonucleotides delivered by poly(N-isopropylacrylamide)/ poly(ethyleneimine) copolymer.
    Dinçer S; Oskay EK; Piskin AK; Zeybek ND; Pişkin E
    J Tissue Eng Regen Med; 2010 Jun; 4(4):284-90. PubMed ID: 19967748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
    Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
    Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.